Avoid common mistakes on your manuscript.
Publisher Correction: European Radiology
In the Graphical Abstract, the clinical translational relevance should be: “The alpha-RECIST and National Cancer Center strategy are optimal methods for determining therapeutic response to a combination of anti-angiogenic therapy plus immunotherapy and facilitating accurate prognostic stratification for HCC in the AFP ≥ 20 ng/mL group and the whole cohort, which may help oncologists for early identification of responders and progression at 6 weeks and clinical decision-making.” Value “20” was incorrectly deleted in typesetting.
The corrected Graphical Abstract is as can be seen below:
![figure a](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00330-023-10575-6/MediaObjects/330_2023_10575_Figa_HTML.png)
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Xu, Y., Yang, Y., Ouyang, J. et al. Publisher Correction: Reclassification of therapeutic response of unresectable hepatocellular carcinoma to anti-angiogenic therapy and immunotherapy using alpha RECIST. Eur Radiol (2024). https://doi.org/10.1007/s00330-023-10575-6
Published:
DOI: https://doi.org/10.1007/s00330-023-10575-6